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Host protection against Candida albicans infection in a model of oral candidiasis involving infection-prone
[DBA/2 (H-2d)] and less infection-prone [BALB/c (H-2d)] mouse strains was analyzed in terms of antibody and
cellular responses, and in terms of cytokine patterns from regional lymph node cells. There was a selective
expansion of g/d1 T-cell receptor cells, which correlated with the patterns of colonization in both mouse
strains, with higher numbers of g/d T cells detected in BALB/c mice. Antigen-induced T-cell proliferation was
significantly higher in BALB/c mice than in DBA/2 mice. Higher levels of serum immunoglobulin G (IgG) and
salivary IgA antibodies were detected in BALB/c mice than in DBA/2 mice, but only after the infection was
cleared. The cervical lymph node cells from infected mice were assessed for interleukin-4 (IL-4), IL-12, and
gamma interferon (IFN-g) mRNA gene expression by reverse transcription-PCR and protein production in the
culture supernatants following restimulation in vitro. In BALB/c mice, an early increase in levels of IL-4,
IFN-g, and IL-12 correlated with rapid elimination of C. albicans. In DBA/2 mice, where resolution of infection
was delayed, IL-4 message expression was delayed and the IL-4 secretion level was lower. Neutralization of IL-4
by multiple injections of an anti-IL-4 monoclonal antibody in BALB/c mice resulted in increased carriage rate
and delayed clearance of the yeasts. Collectively, the data suggest that the T-cell response to C. albicans in the
regional lymph nodes which correlates best with rapid oral clearance of C. albicans is a balanced Th0 cytokine
response involving early secretion of both IFN-g and IL-4.
Candida albicans is a yeast-like fungus that colonizes human
mucosal surfaces of the mouth, vagina, and gastrointestinal
tract as part of the normal microbial flora. It is also an oppor-
tunistic pathogen that can cause stomatitis and vaginitis. Un-
der certain conditions it can invade tissues and cause systemic
infection (6, 17, 19, 32, 43). Both clinical and animal studies
indicate that containment within the oral cavity is in part de-
termined by CD41 T lymphocytes (7, 12–14), while recurrent
vaginal infection is predicated by a reduction in the circulating
Candida-reactive T-cell pool (8). Invasive infection is uncom-
mon in subjects with T-cell deficiency but is common in sub-
jects with neutropenia (2) or neutrophil dysfunction (2), sug-
gesting that different mechanisms operate to contain mucosal
spread compared to those responsible for systemic immunity.
In murine studies to determine the exact mechanism of pro-
tection using genetically manipulated mice or contrived exper-
imental conditions, conflicting results have been obtained as to
the cytokine mix most relevant to protection (24, 27, 33–39).
Resistance to systemic infection in some murine strains iden-
tifies Th1 effector cells producing gamma interferon (IFN-g)
and interleukin-12 (IL-12) as mediators of protection (9, 37,
41, 42). By contrast, in other studies, susceptibility to infection
has been linked to Th2 cells producing IL-4 and IL-10, which
in turn downregulate Th1 effector cells (38, 40). A valuable
natural model of oral infection has been the development of an
oral infection in the BALB/c and DBA/2 mouse strains, which
share the same H-2d major histocompatibility locus complex
but which show different rates of spontaneous clearance from
the buccal cavity (12). In this model the local cellular immune
response is characterized by the recruitment of CD41, CD81,
and g/d T cells within the mucosa (12, 38). The molecular
mechanisms mediating protection, however, remain unclear.
To clarify the mechanisms of protection in this model of oral
candidiasis, we have examined the patterns of cytokine and
antibody response in both naive and primed animals. The re-
sults support the proposal that a balanced (Th0) cytokine re-
sponse is important in mucosal protection in this model of oral
infection.
MATERIALS AND METHODS
Mice. Male BALB/c (H-2d) and DBA/2 (H-2d) mice, 6 to 8 weeks old, were
purchased from the Animal Resource Center, Perth, Western Australia. They
were housed in groups of three to five and provided with food and water ad
libitum. All mice were used after 1 week of acclimatization.
Fungal culture. C. albicans isolate 3630 was obtained from the National Ref-
erence Laboratory, Royal North Shore Hospital, Sydney, Australia. The yeast
cells were cultured in Sabouraud dextrose broth (Oxoid, Basingstoke, Hamp-
shire, United Kingdom) for 48 h at 25°C in a shaking water bath. The blasto-
spores were transferred into fresh medium and cultured at 25°C for a further
18 h. Then the blastospores were collected by centrifugation, washed twice with
phosphate-buffered saline (PBS), and adjusted to 108 blastospores per ml in PBS
until use.
Candida antigen. Freshly cultured C. albicans isolate 3630 organisms were
resuspended in PBS at 1010 cells/ml and then sonicated in an MSE Soniprep set
at an amplitude of 10 for 30 cycles with intermittent cooling and sonication. The
sonicate was centrifuged for 10 min at 2,000 3 g, after which the supernatant was
collected and dialyzed against PBS. After protein estimation, the solution was
filter sterilized and stored in aliquots at 220°C until use.
Oral infection. Mice were anesthetized by intraperitoneal injection with 75 ml
of ketamine-Xylazil (100 mg/ml and 20 mg/ml, respectively). They were orally
inoculated with the blastospores by the method described by Chakir et al. (12).
Briefly, 108 blastospores/ml in PBS were centrifuged at 14,000 3 g for 5 min. The
pellet was recovered on a fine-tip sterile swab (Corsham, MW & E, Wiltshire,
United Kingdom) which was then used for oral inoculation by topical applica-
tion.
Quantitation of oral infection. Groups of mice (three to five per group) were
sacrificed at various time points to determine the number of C. albicans organ-
isms in the oral mucosa. The oral cavity (i.e., cheek, tongue, and soft palate), was
completely swabbed using a fine-tip cotton swab. After swabbing, the cotton end
was cut off and then placed in an Eppendorf tube containing 1 ml of PBS. The
yeast cells were resuspended by mixing on a vortex mixer before culture in serial
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10-fold dilutions on Sabouraud dextrose agar (Oxoid) supplemented with chlor-
amphenicol (0.05 g/liter) for 48 h at 37°C. For histological studies, oral tissues
were fixed in 10% formalin and embedded in paraffin. Tissue sections 5 mm thick
were cut, mounted on glass slides, and then stained with hematoxylin and eosin
(H&E) or periodic acid-Schiff (PAS) stain for fungi. The numbers of blasto-
spores and hyphal forms were enumerated by light microscopy. The results were
expressed as the mean count of five fields at a magnification of 340.
Cell separation and flow cytometry. The cervical lymph nodes (CLN) were
excised from three to five C. albicans-infected mice for each time point after
infection, and single-cell suspensions were prepared (18). Pooled CLN popula-
tions were analyzed in two-color mode using Lysis 2 software and FACSan
cytometry (Becton Dickinson, Mountain View, Calif.). The monoclonal antibod-
ies (MAbs) used for staining were fluorescein isothiocyanate (FITC) conjugated
(H129.19 anti-CD4 and H57-597 anti-a/b T-cell receptor [TCR]) or phyco-
erythrin (PE) conjugated (H53-6.7 anti-CD8a, ID3 anti-CD19, and GL3 anti-a/d
TCR). FITC- or PE-conjugated isotype-matched antibodies were used as nega-
tive controls. All MAbs were purchased from PharMingen (San Diego, Calif.).
At least 10,000 viable cells from each preparation were used for analysis.
Lymphoproliferation assay. Pooled CLN cells in RPMI 1640 medium supple-
mented with 10% fetal calf serum (FCS) were cultured in triplicate at 0.2 3 106
cells per well in wells of a 96-well round-bottom microtiter plate (Nunc, Rosk-
ilde, Denmark). C. albicans antigen was added to each well at a final concentra-
tion of 2.5 mg/ml. The cultures were incubated for 72 h under an atmosphere of
5% CO2 in a humidified incubator. Thymidine incorporation was measured by
pulsing the cells with 1 mCi of 3H-labeled thymidine (Amersham, Aylesbury,
United Kingdom) for the final 6 h of incubation before harvesting and counting.
The results were expressed as mean counts per minute 6 standard errors of the
means (SEM).
Antibody assay. A microplate enzyme-linked immunosorbent assay (ELISA)
was used to quantitate specific antibody in the saliva and serum (37, 38). Immu-
nopolysorb microtiter (Nunc) wells were coated with 50 ml of C. albicans anti-
gen/ml in 0.1 M sodium borate-buffered saline (pH 8.4). Appropriate serial
dilutions of the serum and saliva samples were added to each well. Bound
antibodies were detected by the addition of biotinylated goat anti-mouse immu-
noglobulin G (IgG) or IgA (Sigma-Aldrich) followed by alkaline phosphatase-
conjugated streptavidin (AMRAD, Melbourne, Australia). After addition of the
substrate solution, the optical density of duplicate samples was read at 450 nm
with an ELISA plate reader (Bio-Rad, Richmond, Va.).
RT-PCR. RNA extraction and amplification of synthesized cDNA from lym-
phoid cells have been described elsewhere (29, 39). Briefly, 10 ml of total RNA
extracted from 4 3 106 CLN cells/ml was added to 20 ml of reverse transcriptase
(RT) mix containing 6 ml of 53 RT reaction buffer (250 mM Tris-HCl, 375 mM
KCl, and 15 mM MgCl2), 3 ml of 100 mM dithiothreitol, 1.5 ml of deoxynucle-
otides (10 mM), 1 ml of RNase inhibitor (40 U/ml), 0.5 ml of Moloney murine
leukemia virus (MMLV) RT (200 U/ml), 3 ml of oligo(dT)159, 3 ml of acetylated
bovine serum albumin (BSA; 1 mg/ml), and 2 ml of diethyl pyrocarbonate
(DEPC)-treated water. The cDNA synthesis was carried out at 42°C for 1 h
followed by heating at 72°C for 10 min. PCR amplification was carried out by
adding 5 ml of the first-strand cDNA to the PCR mix containing 1 mM each
primer (20 mM), 1 ml of 4 mM deoxynucleoside triphosphate (dNTP) mix, 5 ml
of 103 PCR buffer, 1.2 ml of 1.5 mM MgCl2, 0.2 ml of Taq DNA polymerase (50
U/ml), and 31 ml of DEPC-treated water. The mixture was subjected to ampli-
fication using a thermal cycler (Hybaid, Ashford, Middlesex, United Kingdom)
set at 94°C for 1 min (IL-4 and G3DPH) and 30 s (for IFN-g), 60°C for 2 min
(IL-4 and G3DPH) and 62°C for 1 min (IFN-g), and 72°C for 3 mins (IL-4 and
G3DPH) and 90 s (for IFN-g), with a final elongation step at 72°C for 10 min.
PCR amplification was carried out for 35 to 40 cycles. PCR fragments were
separated by 2% agarose gel electrophoresis, stained with ethidium bromide, and
then viewed under a UV transilluminator. For IL-4, the sense primer was GAA
TGT ACC AGG AGC CAT ATC and the antisense primer was CTC AGT ACT
ACG AGT ATT CCA; for IFN-g, the sense primer was TCT CTC CTG CCT
GAA GGA C and the antisense primer was ACA CAG TGA TCC TGT GGA
A. The amplified DNA products for IL-4 and IFN-g were 399 and 460 bp,
respectively.
Cytokine assay. CLN cells in RPMI 1640 medium supplemented with 10%
FCS were cultured at 4 3 106 cells per well in the presence of 2.5 mg of C.
albicans antigen/ml in a 24-well plate for 3 days (as described above). The culture
supernatants were collected and then assayed for IL-4, IL-12, and IFN-g by
ELISA using matched-antibody pairs and recombinant cytokines as standards
(PharMingen). Briefly, Immuno-polysorb microtiter plates (Nunc) were coated
with a capture rat monoclonal anti-IL-4 (IgG1), anti-IL-12 (IgG2a), or anti-
IFN-g (IgG1) antibody at 1 mg/ml in sodium bicarbonate buffer (pH 9.6) over-
night at 4°C. The wells were washed and then blocked with 1% BSA before the
culture supernatants and the appropriate standard were added to each well.
Biotinylated rat monoclonal anti-IL-4, anti-IL-12, or anti-IFN-g antibody at 2
mg/ml was added as the second antibody. Detection was done with streptavidin
peroxidase (AMRAD) and TMB (Sigma-Aldrich). The sensitivity of the cytokine
ELISAs was 31 pg/ml. The results were expressed as net Candida-induced counts
from which the background was subtracted.
Infection and treatment with anti-IL-4 MAb. Mice were injected intraperito-
neally (i.p.) with 30 mg of rat anti-recombinant IL-4 (rIL-4) (29) (clone 11B11;
PharMingen) or with the purified rat IgG1 matched isotype in 200 ml of PBS per
mouse at days 1, 3, and 5 after oral infection with 108 yeast cells. The number of
yeasts in the oral cavity was determined as described above.
Statistical analysis. The data were compared using the nonparameteric Mann-
Whitney U test. P values of , 0.05 were considered significant. All calculations
were performed using a statistical software program (StatView; Abacus Con-
cepts, Berkeley, Calif.).
RESULTS
Kinetics of oral infection by C. albicans in BALB/c and
DBA/2 mice. The oral mucosae of BALB/c and DBA/2 mice
were infected with 108 C. albicans blastospores on day 0, after
which time the level of colonization was examined over 28
days. As shown in Fig. 1A, the levels of colonization 6 h after
infection were similar in BALB/c and DBA/2 mice. However,
resistance to infection in BALB/c mice was evident at day 2
after an initial reduction in colonization at day 1 after inocu-
lation, compared with a 1-log-unit increase in the number of
yeasts in DBA/2 mice (P , 0.05). While there was a decrease
FIG. 1. Patterns of colonization with C. albicans in BALB/c and DBA/2 mice. (A) Mice were infected by swabbing the oral mucosa with C. albicans (108 CFU/mL).
At various times indicated, the level of colonization was assessed by swabbing the oral cavity. Data shown are means 6 standard errors for three to five mice. p, P ,
0.05; pp, P , 0.01; ppp, P , 0.0001 (for values from BALB/c versus DBA/2 mice). (B) The numbers of blastospore and hyphae in oral tissues were counted by light
microscopy (magnification, 340) after staining with H&E and PAS stains. Data are means 6 standard errors for three to five mice.
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in colonization in BALB/c and DBA/2 mice on day 4, a 2-log-
unit increase in the number of yeasts occurred on day 6 in
DBA/2 mice (P , 0.001), compared with BALB/c mice. By day
8, the BALB/c mice had no yeasts in the oral cavity, whereas in
DBA/2 mice the number of yeasts was above 3 log units, which
gradually declined to background level by day 15. Cultures of
fecal pellets from mice after inoculation of C. albicans showed
no growth or ,3 CFU per fecal pellet, thus excluding the
possibility that the repeat cycle of infection in DBA/2 mice was
due to coprophagia in the mice.
To determine whether the pattern of infection was charac-
terized by different morphological forms of C. albicans, the
proportions of blastospores and hyphal forms in oral tissues
were enumerated. Figure 1B represents the ratios of blasto-
spores to hyphal forms of Candida in tissue sections of the oral
mucosa in BALB/c and DBA/2 mice. After inoculation, the
ratios of blastospores to hyphal forms were about similar in
DBA/2 and BALB/c mice. By day 2, the ratio was lower in
DBA/2 than in BALB/c mice. On day 4, about equal ratios of
blastospores to hyphae were detected in the two mice strains.
In BALB/c mice, the ratios of blastospores to hyphae contin-
ued to rise over time; when 100% of yeasts present in the oral
mucosa were blastospores on day 6 before they were cleared by
day 8. In marked contrast, a low blastospore-to-hypha ratio was
detected in DBA/2 mice on day 6; then it rose by day 10 before
the yeasts, consisting predominantly of blastospores, were
cleared on day 15.
Cellular response in the CLN. The mean number of cells
recovered from the CLN increased from 9.8 3 106 to 22 3 106
cells per mouse, and from 9.5 3 106 to 18 3 106 cells per
mouse 4 days after infection with C. albicans in BALB/c and
DBA/2 mice, respectively (Table 1). A drop in cell counts on
day 6 followed the clearance of C. albicans in both BALB/c and
DBA/2 mice, but in DBA/2 mice it was followed by a rise in cell
counts after reinfection before decline on day 15. While the
relative proportions of CD191 B cells and the various T-cell
subsets remained constant, there was a significant increase in
the percentage of g/d T cells above the background level dur-
ing the course of infection. In BALB/c mice, the number of g/d
T cells increased five- to sixfold on day 6 and then declined
thereafter when the infection was cleared. In contrast, in
DBA/2 mice, the increase in the numbers of g/d T cells was
cyclical, with maximum levels occurring on days 8 and 10 be-
fore falling to background levels on day 15, when the infection
was cleared.
In vitro stimulation of CLN cells. The effect of C. albicans
colonization on T-cell proliferation was determined in culture
of CLN cells stimulated with C. albicans antigens. As shown in
Fig. 2, there was a significantly higher antigen-stimulated T-cell
proliferative response, which peaked at day 4 (P , 0.05) and
day 10 (P , 0.05), in DBA/2 mice than in unstimulated con-
trols. In contrast, a lower (but significant) increase in the pro-
liferative response in BALB/c mice occurred at day 4 (P ,
0.05) and was maintained thereafter at a similar level after a
peak response at day 6 (P , 0.01). The proliferative response
in DBA/2 mice, however, continued to decline to control levels
by day 28.
Serum and local IgG and IgA antibody responses. As shown
in Fig. 3, an increase in serum IgG antibody levels was detected
in both BALB/c and DBA/2 mice 10 days after infection, with
maximum levels detected on day 15. The levels of IgG antibody
were significantly higher in BALB/c mice compared to DBA/2
mice at days 10 and 15 (P , 0.05) and at day 28 (P , 0.01).
Similarly, significantly higher levels of IgA antibody were de-
tected in the saliva of BALB/c mice compared to DBA/2 mice
at all time points from day 8, with maximum levels at day 15
(P , 0.05), before dropping at day 28 (P , 0.05).













0 0.98 9.75 0.89 10.47
0.25 0.98 12.03 0.90 10.63
1 1.25 15.47 0.90 13.57
2 1.65 18.30 2.00 14.83
4 4.25* 21.87 3.54* 16.97
6 6.50** 17.87 2.20 12.17
8 3.25* 15.00 4.23* 13.47
10 0.94 17.27 5.68** 14.50
15 0.97 14.47 1.00 12.33
28 0.88 11.93 0.92 11.93
a Cell numbers are expressed as counts per mouse, and the percentages of g/d
T cells were significantly different above background. p, P , 0.05; pp, P , 0.01
(compared with background levels).
FIG. 2. Lymphocyte proliferation. CLN cells were stimulated or not with C.
albicans antigen for 3 days, after which time thymidine incorporation was as-
sessed. The results shown are mean counts per minute 6 standard errors for
three mice. p, P , 0.05; pp, P , 0.01 (compared with values from unstimulated
cells).
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Effect of infection on IL-4 and IFN-g mRNA gene expres-
sion. The effect of colonization on mRNA expression of IL-4
and IFN-g in CLN cells was examined by RT-PCR. As shown
in Fig. 4, IL-4 gene expression was detected on day 2 in
BALB/c mice, whereas it was not expressed until day 6 in
DBA/2 mice. While IL-4 gene expression disappeared by day
10 in BALB/c mice, it continued in DBA/2 mice at day 15. In
contrast, IFN-g mRNA gene expression was first detected at
6 h after infection and then gradually declined in BALB/c
mice, whereas it continued strongly in DBA/2 mice over the 28
days.
IL-4, IL-12, and IFN-g production by CLN cells stimulated
with C. albicans antigen. To determine the pattern and the
kinetics of cytokine production following infection, CLN cells
were stimulated with C. albicans antigen for 72 h, after which
time the levels of IL-4 and IFN-g in the culture supernatants
were measured. As shown in Fig. 5, significantly higher levels
of IL-4 were produced at day 2, with maximum levels occurring
at days 4 and 6, in BALB/c mice than in DBA/2 mice at those
times (P , 0.01 and (P , 0.05). In contrast, increases in IFN-g
levels were observed in both BALB/c and DBA/2 mice, but
with significantly higher levels produced in DBA/2 mice at 6 h
and at day 2 after infection than were seen in BALB/c mice at
those times (P , 0.05 and (P , 0.01). By days 4 and 6, IFN-g
production was at its highest level in BALB/c mice compared
to DBA/2 mice, where IFN-g production was at background
levels by day 6 (P , 0.01). While the production of IFN-g
declined, except for a small increase at day 15, in BALB/c mice,
a marked increase in production was detected in DBA/2 mice
at days 8 (P , 0.05) and 10 (P , 0.01). By day 28, the levels of
IFN-g returned to background in both mouse strains.
To determine whether the different levels of IL-4 and IFN-g
production are related to IL-12 production, CLN cells were
isolated at various times from BALB/c and DBA/2 mice that
were infected and then stimulated with C. albicans antigen for
3 days, after which IL-12 was measured in the culture super-
natant. As shown in Fig. 5, significantly higher production of
IL-12 was detected as early as 2 days after infection in DBA/2
mice (P , 0.05). In BALB/c mice, an increase in IL-12 pro-
duction was detected at day 6 and day 8 (P , 0.05). Following
a further increase in DBA/2 mice, IL-12 was maintained at
similar levels for 28 days in both mice strains.
Effect of multiple injections of anti-IL-4 MAb on suscepti-
bility to Candida infection in BALB/c mice. To determine
whether the higher production of IL-4 in BALB/c mice was
associated with rapid clearance of the yeasts, the effect of
anti-IL-4 administration was assessed. Figure 6 demonstrates
that BALB/c mice infected with the yeasts followed by admin-
istration of 30 mg of anti-IL-4 on days 1, 3, and 5 after oral
infection had a higher carriage rate, with a delayed clearance
of the yeasts, compared with untreated controls. However,
there was no detectable difference in the amounts of IFN-g in
CLN cell culture supernatants between anti-IL-4 MAb-treated
and control C. albicans-infected mice (data not shown).
FIG. 3. Serum IgG and salivary IgA antibody levels. IgG and IgA antibody
levels were measured in serum and saliva from infected mice by ELISA. Time
zero represents uninfected mice. The results shown are means 6 SEM for three
mice. p, P , 0.05; pp, P , 0.01 (for values from BALB/c or DBA/2 mice).
FIG. 4. IL-4 and IFN-g mRNA gene expression in CLN cells. Total RNAs
were extracted from CLN cells of mice infected with C. albicans and analyzed by
RT-PCR using cytokine-specific primers. Equivalent loading of each sample was
determined by the G3DPH message.
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Anti-IL-4 MAb-treated C. albicans-infected mice had no
detectable IL-4 in CLN cell culture supernatants in the first 8
days; thereafter, small amounts of IL-4 could be detected (data
not shown).
DISCUSSION
The results of this study demonstrate that host resistance to
C. albicans infection in the oral mucosa in a murine model is
linked to a particular pattern of cytokine response and an
accumulation of g/d T cells in the regional lymph nodes. The
differences between the colonization patterns of C. albicans in
“infection-resistant” BALB/c mice and “infection-prone”
DBA/2 mice following infection correlated with both T-cell
proliferation and the secretion pattern of the cytokines IL-4,
IL-12, and IFN-g. Colonization patterns for both blastospore
and hyphal forms of C. albicans were cyclical, with higher levels
of colonization in DBA/2 mice. The more “infection-resistant”
BALB/c strain showed a single peak, with lower levels of col-
onization and more rapid clearance of C. albicans from the
oral cavity. There was a selective expansion of g/d T cells in the
regional lymph node, which correlated in time with the clear-
ance of infection in both mouse strains. Sustained antigen-
specific T-cell proliferation was produced only in the infection-
resistant BALB/c mouse strain. Higher levels of serum IgG and
salivary IgA antibodies followed resolution of infection in
BALB/c mice, but levels of these antibodies were lower in
DBA/2 mice. In DBA/2 mice, a cyclic colonization pattern with
high numbers of fungi, and relatively delayed clearance of
infection, correlated with high levels of IFN-g and IL-12 soon
after infection and a delayed and blunted IL-4 response. In
contrast, the infection-resistant BALB/c strain showed a lower
and more transient colonization with C. albicans, which corre-
lated with early production of both IL-4 and IFN-g. Neutral-
ization of IL-4 in these mice with an anti-IL-4 MAb (11B11)
directly demonstrated that IL-4 contributed to protection. Col-
lectively, these results indicate that the induction of a balanced
Th1 and Th2 helper cell response characterized by the produc-
tion of both IFN-g and IL-4, and the proliferation of g/d T
cells, contributes to host resistance to C. albicans infection in
oral candidiasis.
The mechanisms of host protection against C. albicans in-
fection have been extensively studied in murine models of
FIG. 5. IL-4, IL-12, and IFN-g production by CLN cells stimulated in vitro.
CLN cells from infected mice were stimulated with C. albicans antigen for 3 days,
after which time the culture supernatants were assayed for cytokines by ELISA.
Time zero represents uninfected mice. The results shown are means 6 SEM for
three to five mice. p, P , 0.05; pp, P , 0.01 (values from BALB/c versus DBA/2
mice).
FIG. 6. Effect of treatment with an anti-IL-4 MAb on resistance to acute
infection with C. albicans. BALB/c mice were injected i.p. with 30 mg of rat
anti-IL-4 or with purified rat IgG1 matched isotype on days 1, 3, and 5 after
challenge with yeast cells. On various days, the number of yeasts in the oral cavity
was determined and the results were expressed as mean CFU 6 SEM for three
to five mice. p, P , 0.05.
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candidiasis in terms of the impact of T-cell cytokines operating
through various effector mechanisms of immunity (10, 11, 29,
31). In invasive candidiasis, neutrophils and macrophages are
involved in host defense (2, 3, 22). A link between resistance
and susceptibility, and T-cell cytokine profiles, has been dem-
onstrated in these models in terms of mortality or survival
(reviewed in reference 2). For instance, IFN-g is rapidly pro-
duced following infection in both resistant and susceptible
mice (27, 41). Neutralizing IFN-g increased the susceptibility
of resistant mice to infection (37), an outcome also achieved by
overproduction of IFN-g mediated by IL-12 (27). In a study of
IFN-g-deficient mice, IFN-g-induced activation of macro-
phages was essential for survival (24). Yet other studies have
shown that IFN-g is not essential for host defense against
systemic candidiasis (34). It is important in such studies to
distinguish among mechanisms that limit mucosal colonization,
those that prevent systemic invasion, and those essential for
survival. Studies involving manipulation of single components
of the host response, while valuable, must be interpreted with
caution. The present study examined mechanisms of host re-
sistance and susceptibility in a natural model of self-limited
oral mucosal candidiasis. Different patterns of colonization
and IFN-g and IL-4 production were compared in an “infec-
tion-resistant” strain (BALB/c) and an “infection-prone” strain
(DBA/2). While IFN-g transcripts were detected early (at 6 h)
in both BALB/c and DBA/2 mice following initial infection
with C. albicans, the production of IFN-g did not on its own
prevent more-protracted colonization in DBA/2 mice.
Whether deficiency of the fifth component of complement in
DBA/2 contributes to the protracted colonization in oral can-
didiasis is unclear. However, several studies with congenic
mice, including those bred from different genetic backgrounds
of the DBA/2 strain, have reported that C5 deficiency is not an
essential factor contributing to the pathogenesis of invasive
candidiasis (1, 2, 28).
The present study showed that high levels of IL-12 and
IFN-g, together with a delayed message expression and lower
production of IL-4, correlated with higher levels of coloniza-
tion and delayed clearance of C. albicans in DBA/2 mice. This
is consistent with the observation which showed that C. albi-
cans infection of the gastric mucosa in susceptible DBA/2 mice
correlates with decreased expression of IL-4 in Peyer’s patches
(10). By contrast, the lower levels of IL-12 and IFN-g, together
with earlier and higher production of IL-4, correlated with a
lower colonization and more-rapid clearance of C. albicans in
BALB/c mice, suggesting that the degree, the kinetics, and the
mix of cytokines may be critical factors in determining the level
of protection after challenge. Both Th1 and Th2 cytokines,
albeit in different amounts with different kinetics of produc-
tion, were present in DBA/2 and BALB/c mice recovering from
oral candidiasis, as was seen in gastric candidiasis (10). Thus,
resistance to primary infection with C. albicans in the oral
mucosa is associated with Th1 and Th2 responses. Support for
a role for IL-4 in clearance was directly demonstrated by the
increased carriage rate and delayed clearance of C. albicans
from the oral mucosae of BALB/c mice following treatment
with anti-IL-4 antibody.
The mechanism of IL-4-enhanced resistance to C. albicans
infection in the oral mucosa is unclear. In primary systemic
candidiasis, IL-4 may limit C. albicans infection through pro-
moting effector mediators of immunity, including the differen-
tiation of effector Th1 cells (29, 30). In particular, IL-4 pro-
motes the development of a protective Th1 response in
systemic and gastric candidiasis (10, 30). Other studies have
shown that mice deficient in IL-4 were more susceptible to
acute systemic infection than normal controls (30, 45), though
no difference in susceptibility to orogastric candidiasis after
challenge was noted (45). These paradoxical findings may be
explained by different experimental models, different mouse
strains, and different routes of challenge and doses of C. albi-
cans to induce systemic or mucosal candidiasis. For example,
intragastric challenge with C. albicans induced a more severe
gastric candidiasis in BALB/c mice than in DBA/2 mice,
whereas the reverse was true for systemic candidiasis (10). In
the present model, acute oral candidiasis was induced by top-
ical application of C. albicans, as opposed to an intragastric
bolus of C. albicans to induce gastric candidiasis (30, 45).
Furthermore, topical application of C. albicans to the oral
mucosa restricts the supply of antigen to the gut-associated
lymphoid tissue (GALT) compartment, limiting modification
of the course of infection via activation of the common muco-
sal immune system (14). Little or no fungus was recovered
from fecal pellets.
In the present study both BALB/c and DBA/2 mice cleared
infection before the onset of antibody production, indicating
that production of serum IgG and secretory IgA antibodies did
not play a significant role in mucosal clearance, in agreement
with findings in murine gastric candidiasis (10). In the latter
model, enhanced production of secretory IgA antibody did not
accelerate the resolution of infection (10). Despite an increase
in cell counts in the CLN after infection, the relative propor-
tions of CD41, CD81, and a/b T cells and B cells remained
constant, suggesting cell recruitment rather than antigen-in-
duced proliferation of cells. However, there was a selective
expansion of g/d T cells, which correlated with the elimination
of C. albicans. While the numbers were low, the increase was
significant, considering the paucity of g/d T cells in peripheral
lymphoid tissues (21). Increased numbers of g/d T cells have
been reported after bacterial, viral, and parasitic infections,
suggesting a role for g/d T cells in the first line of host defense
(25, 26). It has previously been reported that g/d T cells en-
hance resistance to mucosal candidiasis (16, 23), and increased
numbers of g/d T cells in the oral mucosa correlated with the
pattern of colonization in BALB/c and DBA/2 mice infected
with C. albicans (12). It is not clear, however, whether g/d T
cells are a source of IL-4. Although it has been reported that
g/d T cell clones and cell lines are capable of secreting IL-4 (4,
46, 47), we could not demonstrate significant amounts of IL-4
in g/d T cells in these mice (data not shown). It has recently
been reported that g/d T cells can enhance nitric oxide (NO)
production by macrophages in mice injected i.p. with C. albi-
cans (23), further linking g/d T cells with potential mechanisms
of resistance. Furthermore, NO can enhance IL-4 expression
in T cells (15), further influencing the balance of cytokine
secretion. Thus, mucosal containment of C. albicans may de-
pend on the interaction between macrophages and T cells
through the release of NO and IL-4, mediators which have
been reported to enhance the killing of yeast cells by both
neutrophils (5) and macrophages (20, 35) bearing IL-4 surface
receptors. g/d T cells can secrete IFN-g and IL-4, which both
activate macrophages to act directly on C. albicans (35, 44).
Preliminary studies with the current model show high levels of
NO in saliva to support this hypothesis (unpublished results).
In summary, analysis of regional lymph node cell popula-
tions provides data consistent with current ideas about cyto-
kine function in experimental models of infection. The findings
presented in this study of a model of oral candidiasis indicate
that the production of IL-4 and IFN-g is critical to the reso-
lution of mucosal infection in the intact animal. The early
appearance of IL-4 production suggests the importance of this
cytokine in enhancing immunity against C. albicans infection in
the oral mucosa, a correlation directly supported by data ob-
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tained following treatment with anti-IL-4 antibody. The con-
current presence of high levels of IL-12 and IFN-g supports
the concept of a balanced Th1 and Th2 response as being an
efficient host defense mechanism in clearing oral mucosal in-
fection.
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